SGX - Singapore Exchange Ltd.



New Listings

Annual Report/Fin. Report

Company´s All-In-One Info

Research Reports

AGM Schedules

Prospectus/Circulars

Announcements

Stock/Indices List

ISIN Code Download

Corporate Info

Corporate Action

Warrants

Assistance Programme

Results Reporting

Market Statistics

Secondary Listings

Watchlist

Home » Listed Companies » Corporate Information


View Results By
By Company Name By Country By Market Corporate Distribution


  Corporate Information By Company Name :

   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z   0-9  


ASIAPHARM GROUP LTD

Full Company Name:AsiaPharm Group Ltd
Incorporated in :BERMUDA
Incorporated on :2 Jul 2003
ISIN Code :BMG062191025
Registered Office :Clarendon House
2 Church Street
Hamilton HM 11
Bermuda
Telephone:65 62200119
Fax:65 62200282
Secretary:Lim Ka Bee
Caroline Yeo Poh Noi
Ira Stuart Outerbridge III (Asst)
Link to Internet Websitehttp://www.asiapharm.biz/

SHARE CAPITAL
-
Authorised Capital :USD100,000,000 ordinary sharesPar Value :USD0.020
Issued & Paid-up Capital :USD9,841,598 Trading Currency :SGD

LISTINGS
Listed on 5 May 2004 on SGX Mainboard

REGISTRARS
Codan Services Limited (Bermuda)
Boardroom Corporate & Advisory Services Pte Ltd
(Singapore)

REGISTRAR ADDRESS
Codan Services Limited
Clarendon House
2 Church Street
Hamilton HM 11
Bermuda

Boardroom Corporate & Advisory Services Pte Ltd
3 Church Street #08-01
Samsung Hub
Singapore 049483


AUDITORS
Ernst & Young, Hong Kong

BACKGROUND
The Company was incorporated under the laws of Bermuda on 2 July 2003. It is the holding company of AsiaPharm Investments Ltd which owns 95.93 percent of the shareholdings of Shandong Luye Pharmaceutical Co Ltd. Shandong Luye owns 69 percent and 80 percent of the shareholdings of Shandong Luye Natural Drug Research and Development Co Ltd and Yantai Luye Drugs Trading Co Ltd respectively.

The Group specialises in the research, development, production and sale of pharmaceutial drugs and new formulations for chemical drugs, the sale of R&D results and patents for new drugs, and the provision of research services on a contract basis.

To reach its customers, the group has established a distribution network of 35 sales support offices, covering 30 provinces, municipals and autonomous regions, reaching aprroximately 2,500 hospitals.


Information Last updated on 05/14/2008 07:00:32 AM